100 Questions & Answers About Myelodysplastic Syndromes

100 Questions & Answers About Myelodysplastic Syndromes

MDS is a lethal blood illness that affects as a lot of as 50 per 100,000 people over the age of 70. The disorder is five times a lot more prevalent than AML, a form of leukemia. Whether you're a newly diagnosed patient, a survivor, or loved one of an individual suffering from MDS, this book offers aid. The only text offered to provide both the doctor's and patient's views, 100 Questions & Answers About Myelodysplastic Syndromes, provides practical, authoritative answers to 100 of the most frequent questio

100 Questions & Answers About Myelodysplastic Syndromes Specs:

• ISBN13: 9780763753337
• Condition: New
• Notes: BRAND NEW FROM PUBLISHER! Purchase WITH CONFIDENCE, Over one million books sold! 98% Positive feedback. Compare our books, costs and service to the competition. 100% Satisfaction Guaranteed

Grab and acquire 100 Questions & Answers About Myelodysplastic Syndromes appropriate now!

[wprebay kw="myelodysplastic+syndromes" num="5" ebcat="-1"] [wprebay kw="myelodysplastic+syndromes" num="6" ebcat="-1"]

Related Myelodysplastic Syndromes Items

Irritable Bowel Syndrome Relief Secrets - * $18.67 Payout! 55% Commiss

Irritable Bowel Syndrome Relief Secrets - * .67 Payout! 55% Commiss
Top Irritable Bowel Syndrome Remedy *amazing Conversions* The Latest Affiliate tools here: www.natural-irritable-bowel-syndrome-relief.com/af filiate.html
Irritable Bowel Syndrome Relief Secrets - * .67 Payout! 55% Commiss

Get rid of Restless Leg Syndrome
Over 12 Million Individuals Suffer From Restless Leg Syndrome. This item is converting like crazy! Assist people rid restless legs and make funds doing it!
Get rid of Restless Leg Syndrome

Conquering Carpal Tunnel Syndrome
How to diagnose, prevent, treat and recover from carpal tunnel syndrome. Affiliates page offered with lots of material all ready to use. Low cost + small competition + 75% commission = large earnings!
Conquering Carpal Tunnel Syndrome
[wprebay kw="myelodysplastic+syndromes" num="3" ebcat="-1"] [wprebay kw="myelodysplastic+syndromes" num="4" ebcat="-1"]

Symbol for People with AA & MDS

Check out these myelodysplastic syndromes mds images:

Symbol for Folks with AA & MDS

Image by Knomad
Our friend Barney has MDS (myelodysplastic syndrome). Nowadays he is in the hospital receiving radiation to kill his bone marrow in preparation for a bone marrow transplant Friday. If all goes nicely he will be in the hospital for a minimum of 6 weeks.

This bracelet is a symbol of the Aplastic Anemia & MDS International Foundation, which is the oldest and largest patient advocate and support organization for bone marrow diseases, offering life-saving hope, knowledge, and support to hundreds of thousands of patients and their families around the world.

Please upload this photo to your own photo stream to show your support for Barney and the thousands of other people who have bone marrow diseases and tag it with BRAVERY.

Also my spouse SplinterGroup was diagnosed with MDS two weeks ago. He took the photo of the bracelet which was a gift from Barney.

My grandma has myelodysplastic syndrome. How is this related to Leukemia (if it is)? She's tried various

Question by AJB: My grandma has myelodysplastic syndrome. How is this related to Leukemia (if it is)? She's tried various
treatments. Had transfusions, which went to each and every three weeks. Now is starting Chemo. She is 72. Any ino would be fantastic!
Thanks.


Best answer:

Answer by Kim J
My mother-in-law was diagnosed with MDS back in January 2008. She had four rounds of chemo and then was told she was performing okay six weeks ago. She has had several blood and platelet transfusions. This past weekend she was admitted to the hospital since she could not handle the discomfort. Here, the MDS turned into Acute Leukemia and was told she only had a couple of weeks. MDS is a "shadow" leukemia. Maintain a close eye on her blood and platelet counts. My mother-in-law is also 74 and not in the best support before she was diagnosed. Very best of luck to you!

Add your own answer in the comments!

Some facts about leukemia treatment options

by Ed Yourdon

Article by Groshan Fabiola

Leukemia has two key varieties: acute and chronic. In what concerns acute leukemia, there are two forms: if leukemia entails lymphocytes, we are dealing with acute lymphoblastic leukemia, and if it entails myeloid cells, is referred to as acute myelogenous leukemia. Depending on the particular cell that has turn into malignant, there can be several various sorts of acute lymphoblastic leukemia and acute myelogenous leukemia.It was seen that chronic leukemia affects primarily the myeloid cells in the bone marrow. This is called chronic myelogenous leukemia, and is found mostly in adults, but kids and teenagers can develop it too.We should mention that there exists a disorder of the bone marrow identified as myelodysplastic syndrome. Typically referred to as a pre-leukemia syndrome since patients with it have a significantly increased risk of creating leukemia, this syndrome is usually linked with low blood cell counts and increased requirements for transfusions.

Allogeneic bone marrow stem cell transplantation is used to treat a variety of childhood leukemias or cancers and myelodysplastic syndrome that involve the cells inside the bone marrow. In this transplant, there are employed one more person's bone marrow cells to restore bone marrow right after high dose chemotherapy and radiation therapy.As an benefit of an allogeneic transplant over an autologous transplant we can mention the "graft-versus-leukemia effect". The donor's healthy bone marrow kills residual leukemia cells, and in this way decreases the patient's opportunity of relapse.As a disadvantage of an allogeneic bone marrow stem cell transplant we can mention the risk of graft-versus-host disease. This happens when the other person's bone marrow attacks the recipient's body. In this way, there appears a disease that affects the skin, liver and numerous other organs. In this case, therapy with immunosuppressive drugs is needed.

When a matched donor is obtainable, there can be performed transplantation for high-risk leukemia patients in first remission. In quite high-risk patients, like those with leukemia who fail to obtain 1st remission with chemotherapy, there can be carried out an unrelated donor transplant as soon as remission is achieved. As eligible we can mention infants with leukemia, youngsters with high-risk lymphoblastic leukemia and young children with acute myelogenous leukemia. Also, young children with myelodysplastic syndrome are eligible for transplant as soon as the diagnosis is established.

Many young children with acute leukemias whose leukemia has relapsed can have bone marrow stem cell transplantation. Transplantation can be from related donors like brothers, sisters, parents, and occasionally more distant relatives such as cousins and grandparents.Also, transplantation can be from matched unrelated donors, such as umbilical cord blood.In what concerns youngsters with chronic myelogenous leukemia who can't be put into total remission with drugs, they really should undergo a transplant as early as probable in the course of the disease.

About the Author

For much more resources on different leukemia related issues like leukemia symptoms, leukemia causes and a lot of more go to http://www.leukemia-guide.com.

This patient education video explains MDS. It initial discusses its symptoms and causes and how it is diagnosed and treated. It also includes ideas for coping with MDS.

Myelodysplastic syndromes

Post by Subramani

Myelodysplastic syndrome (MDS) refers to a group of clonal stem cell disorders characterized by maturation defects resulting in ineffective hematopoiesis and an increased risk of transformation to AML. In patients with MDS, the bone marrow is partly or wholly replaced by the clonal progeny of a mutant multipotent stem cell that retains the capacity to differentiate into red cells, granulocytes, and platelets, but in a manner that is both ineffective and disordered. As a result, the bone marrow is typically hypercellular or normocellular, but the peripheral blood shows pancytopenia. MDS arises in two distinct settings:

Idiopathic or main MDS,occuring mainly in patients over age 50, frequently develops insidiously.

Therapy related MDS (t-MDS), a complication of previous myelosuppressive drug or radiation therapy, typically appears 2 to 8 years soon after exposure.

All forms of MDS can transform to AML, but transformation occurs most rapidly and with highest frequency in patients with t-MDS. Although characteristic morphologic adjustments are normally seen in the marrow and the peripheral changes are typically seen in the marrow and the peripheral blood, definitive diagnosis regularly demands correlation with other laboratory tests. Cytogenetic analysis is particularly helpful in confirming the diagnosis becauswe certain chromosomal aberrations are typically observed.

The pathogenesis of MDS is unknown. Although the marrow is typically hypercellular at diagnosis it could also be normocellular or, less commonly, hypocellular. Given this, the usual explanation for suppression of normal hematopoiesis (crowding out of regular elements) is challenging to apply, leading to the suggestion that MDS might arise out of a background of stem cell damage. Both main MDS and t-MDS occuring right after exposure to radiation or alkylating chemotherapeutic drugs are linked with comparable clonal chromosomal abnormalities, including monosomy 5 and monosomy 7 deletions of 5q and 7q trisomy 8 and deletions of 20q

Clinical Course

Primary MDS affects primarily individuals older than 60 years of age. As in acute leukemia patients with this disorder present with weakness, infections, and hemorrhages, all owing to pancytopenia. Approximately half of the patients are asymptomatic, and the disease is discovered following incidental blood tests.

On the basis of particular morphologic functions in the marrow and peripheral blood, primary MDS is divided into five categories, every with a somewhat diverse risk for transformation to overt AML. In general subtypes that are defined by having a higher proportion of blast cells in the marrow or peripheral blood are linked with a poorer prognosis. The presence of several clonal chromosomal abnormalities and the severity of peripheral blood cytopenias are independent risk aspects that also portend a worse outcome.

The median survival in primary MDS varies from 9 to 29 months, but some individuals in good prognostic groups could live for 5 years or more. Overall, progression to AML occurs in 10 to 40% of individuals and is usually accompanied by the appearance of extra clonal cytogenetic modifications. Other patients succumb to complications of thrombocytopenia (bleeding) and neutropenia (infection). The outlook is even far more grim in ptients with t-MDS, who have an overall median survival of only 4 to 8 months. Cytoopenias tend to be far more severe than in primary MDS, and many patients progress rapidly to AML.

Treatment choices in MDS are limited. In younger patients, allogeneic bone marrow transplantation provides some hope for reconstitution of typical hematopoiesis and long term survival. Older patients with MDS are treated supportively with antibiotics and blood product transfusions.

About the Author

For far more details about disease and treatment check out http://www.medicalhealthcenter.net

Myelodysplastic Syndrome and Leukemia

by [phil h]

Post by Groshan Fabiola

Considered to be a benign illness for years, Myelodysplastic Syndrome (MDS) is nowadays known to pose a serious threat to individuals it affects. Recent studies have revealed that MDS is actually a malignant illness that can further lead to leukemia. Due to this fact, Myelodysplastic Syndrome is also referred to as pre-leukemia illness.

Comparable to leukemia, MDS triggers an overproduction of abnormal blood cells that eventually outnumber their healthy counterparts. The cells involved in causing the illness are known as blasts and they originate in the bone marrow. Dysfunctional blasts multiply at abnormally fast rates and accumulate in the marrow or in the bloodstream. These functionless cells perturb the production of typical blood cells, causing a decrease in the number of red blood cells, white blood cells and platelets. As a result, men and women who suffer from MDS also have anemia, (due to fewer red blood cells), impaired immune system (due to fewer white blood cells) and experience slow healing (due to fewer platelets).

Several patients diagnosed with MDS are at risk of developing leukemia. In order to block the progression of MDS and to stop the occurrence of leukemia, most patients receive remedies with decitabine, a new drug that is presently under testing.

Even though most patients diagnosed with MDS respond well to remedies with mild chemotherapy drugs and decitabine, they generally experience relapse after completing the prescribed course of medications. MDS has a pronounced recurrent character and regardless of its high curability in the initial stages of the illness, it becomes really challenging to treat in later stages of evolution.

Oncologists have noticed the truth that patients who relapse also grow to be less responsive to second remedies. The precise factors why most patients with MDS fail to respond to re-treatment are still unknown. Even so, this difficulty might be corrected by extending the duration of initial treatments. Medical scientists explain that a single long-term course of chemotherapy drugs and decitabine may possibly offer far better results than frequently repeated shorter remedies. They sustain that by extending the treatment with mild chemotherapy drugs and decitabine beyond the margin of remission, patients with MDS are less likely to relapse. In addition, medical scientists claim that patients who attain remission need to follow ongoing maintenance remedies in order to avoid the recurrence of the illness.

Recently conducted experiments have confirmed the fact that long-term treatments offer far better outcomes than repeated remedies in overcoming MDS. Patients who receive short-term remedies not only encounter relapse, but they are also a lot more exposed to developing acute leukemia and other severe forms of blood cancer. In order to prevent this from happening, an extended low-dose initial treatment with decitabine followed by maintenance treatments may be the greatest alternative for patients diagnosed with MDS.

About the Author

You can find wonderful pieces of inforation on diverse leukemia subjects like childhood leukemia, acute leukemia and several much more pay a visit to http://www.leukemia-guide.com

Much more Myelodysplastic Syndromes Articles

Myelodysplastic Syndromes - A Practical Guide

Some recent myelodysplastic syndromes auctions on eBay:

[wprebay kw="myelodysplastic+syndromes" num="0" ebcat="-1"]
[wprebay kw="myelodysplastic+syndromes" num="1" ebcat="-1"]
[wprebay kw="myelodysplastic+syndromes" num="2" ebcat="-1"]

Q&A: What is the difference between Myelodysplastic syndrome and chronic myeloid leukemia?

Question by Allen G: What is the difference between Myelodysplastic syndrome and chronic myeloid leukemia?



Finest answer:

Answer by Denisedds
Myelodysplastic syndromes are bone marrow stem cell disorders that cause inefficient blood production. CML is unregulated growth of myeloid cells in the bone marrow and the accumulation of these cells in the blood. It is also a marrow stem cell disorder.

What do you feel? Answer below!

Detailed Information on Myelodysplastic Syndromes

Write-up by Alicia Stock

Myelodysplastic syndrome (MDS) refers to a heterogeneous group of closely linked clonal hematopoietic disorders. Myelodysplastic syndromes (MDS) are a group of diseases that involve the bone marrow and blood. The bone marrow in myelodysplastic syndrome is normally a lot more active than normal and yet the numbers of blood cells in the circulation are reduced. This is because most of the cells being produced in the bone marrow are defective and are destroyed just before they leave the bone marrow to enter the blood stream. The hallmark of the myelodysplastic syndromes is the combination of a hyperactive marrow with low blood cell counts.

A reduction in numbers of all kinds of blood cell is referred to as pancytopaenia. The other widespread feature of the myelodysplastic syndromes is abnormality in the appearance of the bone marrow and blood cells. These abnormalities are characteristic of the condition. MDS may well be linked to heavy exposure to several chemicals, such as specific solvents or pesticides, or to radiation. MDS can also be caused by treatment with chemotherapy or radiation therapy for other diseases. This is known as treatment-related MDS or secondary MDS. The symptoms of myelodysplastic syndrome are related to the lack of regular blood cells.

Lack of red blood cells outcomes anemia (leading to tiredness and shortness of breath). Lack of white blood cells leaves the body open to infection. Lack of platelet cells makes it accomplish for the blood to clot (leading to unusual bruising or bleeding) Various individuals are affected in different approaches by myelodysplastic syndrome, and its symptoms can range from mild to really severe. Some people might only have long-term (chronic) anemia. MDS typically occurs in older men and women, normally starting following age 50. Myelodysplastic syndrome is rarely inherited. MDS can affect individuals of any age, much more than 80% of instances are in folks over age 60.

Men are more likely than females to create MDS. This is most marked in the typical older patient group. The myelodysplastic syndromes are accomplished to treat simply because of the unusual mixture of hyperactive marrow but not sufficient blood cell production. People with high risk myelodysplasia may possibly only will need supportive treatment to assist improve any symptoms caused by low blood counts. Others may possibly need chemotherapy, or it may possibly be probable for a little number of people to have a stem cell transplant. Cytotoxic chemotherapy is utilized in MDS patients with growing myeloblasts. Supportive care includes transfusion of RBCs or platelets.

About the Author

Alicia Stock writes articles for haircuts guidelines. She also writes articles for hairstyles updos and hairstyles secrets.

Find A lot more Myelodysplastic Syndromes Symptoms Articles